Ethnicity and socio-economic status affects the incidence and survival of hepatosplenic T-cell lymphoma
![British Journal of Haematology on X: "Commentary: Moving CAR-Ts to the outpatient clinic https://t.co/2f6SJF2E6K #lymsm #TCellRx @WileyOnc_Hem https://t.co/V9LVIxYfrP" / X British Journal of Haematology on X: "Commentary: Moving CAR-Ts to the outpatient clinic https://t.co/2f6SJF2E6K #lymsm #TCellRx @WileyOnc_Hem https://t.co/V9LVIxYfrP" / X](https://pbs.twimg.com/media/F_E1QECXgAANfS_.jpg:large)
British Journal of Haematology on X: "Commentary: Moving CAR-Ts to the outpatient clinic https://t.co/2f6SJF2E6K #lymsm #TCellRx @WileyOnc_Hem https://t.co/V9LVIxYfrP" / X
![Moulis et al. “Registries in immune thrombocytopenia in Europe: the European Research Consortium on Immune thrombocytopenia (ERCI) network”. Br J Haematol 2022; online ahead of print – Erci Moulis et al. “Registries in immune thrombocytopenia in Europe: the European Research Consortium on Immune thrombocytopenia (ERCI) network”. Br J Haematol 2022; online ahead of print – Erci](https://www.ercigroup.org/wp-content/uploads/2022/05/2-Moulis_preview.jpg)
Moulis et al. “Registries in immune thrombocytopenia in Europe: the European Research Consortium on Immune thrombocytopenia (ERCI) network”. Br J Haematol 2022; online ahead of print – Erci
BR J Haematol - 2022 - Shaulov - Early Integration of Palliative Care For Patients With Haematological Malignancies | PDF | Palliative Care | Leukemia
![British Journal of Haematology on X: "How to discover exceptional venetoclax responders in AML/MDS? https://t.co/Bcb0wqDa8O https://t.co/FxjhO7usgx" / X British Journal of Haematology on X: "How to discover exceptional venetoclax responders in AML/MDS? https://t.co/Bcb0wqDa8O https://t.co/FxjhO7usgx" / X](https://pbs.twimg.com/media/F-RVWVeWUAEwl4V.jpg:large)
British Journal of Haematology on X: "How to discover exceptional venetoclax responders in AML/MDS? https://t.co/Bcb0wqDa8O https://t.co/FxjhO7usgx" / X
![Br J Haematol - 2020 - Baker - Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis.pdf Br J Haematol - 2020 - Baker - Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis.pdf](https://image.slidesharecdn.com/brjhaematol-2020-baker-guidelinesonthelaboratoryaspectsofassaysusedinhaemostasisandthrombosis-230408204232-ee526b58/85/br-j-haematol-2020-baker-guidelines-on-the-laboratory-aspects-of-assays-used-in-haemostasis-and-thrombosispdf-3-320.jpg?cb=1680986877)
Br J Haematol - 2020 - Baker - Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis.pdf
![Guideline for the diagnosis and management of marginal zone lymphomas: a british society of haematology guideline Guideline for the diagnosis and management of marginal zone lymphomas: a british society of haematology guideline](https://christie.openrepository.com/bitstream/handle/10541/626719/Br%20J%20Haematol%20-%202023%20-%20Walewska%20-%20Guideline%20for%20the%20diagnosis%20and%20management%20of%20marginal%20zone%20lymphomas%20%20A%20British%20Society.pdf.jpg?sequence=3&isAllowed=y)
Guideline for the diagnosis and management of marginal zone lymphomas: a british society of haematology guideline
BR J Haematol - 2015 - Killick - Guidelines For The Diagnosis and Management of Adult Aplastic Anaemia | PDF | Hematopoietic Stem Cell Transplantation | Hepatitis
![Br J Haematol - 2020 - Baker - Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis.pdf Br J Haematol - 2020 - Baker - Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis.pdf](https://image.slidesharecdn.com/brjhaematol-2020-baker-guidelinesonthelaboratoryaspectsofassaysusedinhaemostasisandthrombosis-230408204232-ee526b58/85/br-j-haematol-2020-baker-guidelines-on-the-laboratory-aspects-of-assays-used-in-haemostasis-and-thrombosispdf-4-320.jpg?cb=1680986877)
Br J Haematol - 2020 - Baker - Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis.pdf
![PDF) Addendum to British Society for Haematology Guidelines on Investigation and Management of Antiphospholipid syndrome, 2012 (Br. J. Haematol. 2012; 157: 47–58): use of direct acting oral anticoagulants PDF) Addendum to British Society for Haematology Guidelines on Investigation and Management of Antiphospholipid syndrome, 2012 (Br. J. Haematol. 2012; 157: 47–58): use of direct acting oral anticoagulants](https://i1.rgstatic.net/publication/338577179_Addendum_to_British_Society_for_Haematology_Guidelines_on_Investigation_and_Management_of_Antiphospholipid_syndrome_2012_Br_J_Haematol_2012_157_47-58_use_of_direct_acting_oral_anticoagulants/links/5e1db78b299bf1232603c41a/largepreview.png)
PDF) Addendum to British Society for Haematology Guidelines on Investigation and Management of Antiphospholipid syndrome, 2012 (Br. J. Haematol. 2012; 157: 47–58): use of direct acting oral anticoagulants
![PDF) Addendum to the British Committee for Standards in Haematology (BCSH): Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant, 2004 (Br. J Haematol 2004,126,11-28) PDF) Addendum to the British Committee for Standards in Haematology (BCSH): Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant, 2004 (Br. J Haematol 2004,126,11-28)](https://i1.rgstatic.net/publication/304026255_Addendum_to_the_British_Committee_for_Standards_in_Haematology_BCSH_Guidelines_for_the_use_of_fresh-frozen_plasma_cryoprecipitate_and_cryosupernatant_2004_Br_J_Haematol_200412611-28/links/5fc50c01299bf1a422c2fdb9/largepreview.png)